CIS is First in Louisiana to Use AVEIR™ Leadless Pacemaker

Nicholls and LSU Health New Orleans Partner to Offer Culinary Medicine Program
July 19, 2022
Restore or Retreat Announces New Executive Director, Joseph Orgeron
July 19, 2022
Nicholls and LSU Health New Orleans Partner to Offer Culinary Medicine Program
July 19, 2022
Restore or Retreat Announces New Executive Director, Joseph Orgeron
July 19, 2022

Cardiovascular Institute of the South (CIS) has announced Dr. Robert Drennan, electrophysiologist at CIS, is the first in Louisiana to use the Abbott Aveir™ VR Leadless Pacemaker to treat abnormal heart rhythm.

The procedure took place in the catheterization laboratory at Baton Rouge General Medical Center on July 15. The device is wireless and battery-powered that sends mild, painless electrical signals to the heart to keep the organ in regular rhythm. The device is a leadless pacemaker. According to the release, the Abbott Aveir™ Leadless Pacemaker (LP) is the next evolution in leadless technology that has been designed for chronic retrieval using a dedicated retrieval catheter. It is smaller than a AAA battery measuring just 38mm. It features twice the projected battery life at 10.3 years and brings fewer lead-related complications compared to transvenous pacemakers with wires. It also offers mapping capability prior to fixation to help reduce the number of repositioning attempts, and provides an expandable platform to later support a dual chamber pacing system, once regulatory approved.


“We want our patients to not only live longer, but better,” said Dr. Drennan, “This device offers many advantages to patients in need of a pacemaker, with fewer post-implant restrictions and no lead-related complications to give them a better quality of life moving forward. It also gives the patient and the physician the ability to upgrade as technology continues to advance.”

Learn more about the therapy here.